1. Home
  2. SND vs KRRO Comparison

SND vs KRRO Comparison

Compare SND & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Sand Inc.

SND

Smart Sand Inc.

HOLD

Current Price

$5.35

Market Cap

99.3M

Sector

Industrials

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$11.22

Market Cap

101.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SND
KRRO
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.3M
101.1M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
SND
KRRO
Price
$5.35
$11.22
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$54.60
AVG Volume (30 Days)
412.6K
291.1K
Earning Date
03-02-2026
03-17-2026
Dividend Yield
2.80%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$335,471,000.00
$7,371,000.00
Revenue This Year
N/A
$145.97
Revenue Next Year
N/A
N/A
P/E Ratio
$53.67
N/A
Revenue Growth
18.98
N/A
52 Week Low
$1.76
$5.20
52 Week High
$5.39
$55.89

Technical Indicators

Market Signals
Indicator
SND
KRRO
Relative Strength Index (RSI) 64.77 54.35
Support Level $4.64 $10.81
Resistance Level $5.04 $12.46
Average True Range (ATR) 0.26 1.08
MACD -0.00 -0.05
Stochastic Oscillator 77.97 33.02

Price Performance

Historical Comparison
SND
KRRO

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: